Resource Capital (RSO) 11.59 $RSO Resource Capital

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Resource Capital (RSO) 11.59 $RSO

Resource Capital Shares Down 41.7% Since SmarTrend's Sell Call (RSO)
Comtex SmarTrend(R) - Mon Nov 16, 9:51AM CST
SmarTrend identified a Downtrend for Resource Capital (NYSE:RSO) on January 8th, 2015 at $19.50. In approximately 10 months, Resource Capital has returned 41.69% as of today's recent price of $11.37.
RSO: 11.59 (+0.04)

Warning: These 5 Double-Digit Dividend Yields Are in Imminent Danger of Getting Cut
at The Street - Fri Nov 13, 2:46PM CST
If you own any of these risky double-digit dividend payers, get rid of them now before they crash and pull you down with them.
MEMP: 4.32 (-0.33), RSO: 11.59 (+0.04), NMM: 4.53 (-0.32), HCLP: 6.88 (-0.42), UAN: 8.53 (+0.04)

Moving Ahead of Averages, Technical Review - Research on Celadon Group, IXYS, REX American Resources and Resource Capital
ACCESSWIRE - Tue Nov 10, 6:45AM CST
NEW YORK, NY / ACCESSWIRE / November 10, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Celadon Group Inc. (NYSE: CGI), IXYS Corp. (NASDAQ: IXYS), REX American Resources Corp. (NYSE: REX) and Resource Capital Corp. (NYSE: RSO). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
RSO: 11.59 (+0.04), IXYS: 12.04 (+0.01), REX: 56.01 (-1.28), CGI: 13.31 (+0.03)

Resource Capital Shares Down 35.8% Since SmarTrend's Sell Call (RSO)
Comtex SmarTrend(R) - Mon Nov 09, 9:26AM CST
SmarTrend identified a Downtrend for Resource Capital (NYSE:RSO) on January 8th, 2015 at $19.50. In approximately 10 months, Resource Capital has returned 35.85% as of today's recent price of $12.51.
RSO: 11.59 (+0.04)

Final Deadline: Lundin Law PC Announces Securities Class Action Against Resource Capital Corp. and Urges Shareholders to Contact the Firm Before November 9, 2015 Deadline
Business Wire - Fri Nov 06, 2:38PM CST
Lundin Law PC announces a class action lawsuit has been filed against Resource Capital Corp. ("Resource Capital" or the "Company" (NYSE: RSO) concerning possible violations of federal securities laws between March 2, 2015 and August 4, 2015. Investors who purchased or otherwise acquired shares should contact the Firm before the lead plaintiff motion deadline.
RSO: 11.59 (+0.04)

3-Day Deadline Alert: Law Offices of Howard G. Smith Reminds Resource Capital Corp. Investors of Upcoming Lead Plaintiff Deadline
Business Wire - Fri Nov 06, 11:04AM CST
Law Offices of Howard G. Smith reminds investors of the upcoming November 9, 2015 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Resource Capital Corp. ("Resource Capital" or the "Company" (NYSE: RSO) investors who purchased shares between March 2, 2015 and August 4, 2015, inclusive (the "Class Period". Investors who suffered losses of over $25,000 on their investment in Resource Capital securities are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights.
RSO: 11.59 (+0.04)

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Resource Capital Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of November 9, 2015 - RSO
GlobeNewswire - Thu Nov 05, 1:31PM CST
The following statement is being issued by Levi & Korsinsky, LLP:
RSO: 11.59 (+0.04)

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Ongoing Investigation of Resource Capital Corp. and Strongly Advises Shareholders to Contact the Firm
Business Wire - Wed Nov 04, 7:25PM CST
Lundin Law PC announces it is investigating claims against Resource Capital Corp. ("Resource Capital" or the "Company" (NYSE: RSO) concerning possible violations of federal securities laws between March 2, 2015 and August 4, 2015. The investigation is related to allegations that certain statements issued by Resource Capital were false and misleading concerning the Company's financial performance.
RSO: 11.59 (+0.04)

Resource Capital Corp. Reports Results for Three and Nine Months Ended September 30, 2015
Marketwired - Tue Nov 03, 8:39PM CST
Resource Capital Corp. (NYSE: RSO)
RSO: 11.59 (+0.04)

Resource Capital Down 34.2% Since SmarTrend Downtrend Call (RSO)
Comtex SmarTrend(R) - Fri Oct 30, 4:58PM CDT
SmarTrend identified a Downtrend for Resource Capital (NYSE:RSO) on January 8th, 2015 at $19.50. In approximately 10 months, Resource Capital has returned 34.15% as of today's recent price of $12.84.
RSO: 11.59 (+0.04)

Glancy Prongay & Murray LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit against Resource Capital Corp.
Business Wire - Thu Oct 29, 9:30AM CDT
Glancy Prongay & Murray LLP ("GPM" reminds investors that a class action complaint has been filed on behalf of a class of Resource Capital Corp. ("Resource Capital" or the "Company" (NYSE: RSO) investors who purchased shares between March 2, 2015 and August 4, 2015, inclusive (the "Class Period". Resource Capital investors have until November 9, 2015 to file a lead plaintiff motion. Investors who are interested in learning more about their legal rights are encouraged to contact GPM to discuss their legal rights.
RSO: 11.59 (+0.04)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Resource Capital Corp. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of November 9, 2015 - RSO
ACCESSWIRE - Wed Oct 28, 12:40PM CDT
NEW YORK, NY / ACCESSWIRE / October 28, 2015 / The following statement is being issued by Levi & Korsinsky, LLP:
RSO: 11.59 (+0.04)

ALERT: Morgan & Morgan Reminds Investors That a Class Action Lawsuit Has Been Filed Against Resource Capital Corp. and of the November 9, 2015 Lead Plaintiff Deadline - RSO
GlobeNewswire - Tue Oct 27, 3:14PM CDT
Morgan & Morgan reminds investors that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of purchasers of Resource Capital Corp. ("Resource Capital" or the "Company" (NYSE:RSO) common stock from March 2, 2015 through August 4, 2015, inclusive (the "Class Period". The lawsuit seeks to recover damages for Resource Capital investors under the federal securities laws.
RSO: 11.59 (+0.04)

American Capital Q3 Earnings Miss, Book Value Diminishes
Zacks Equity Research - Zacks Investment Research - Tue Oct 27, 9:40AM CDT
American Capital Agency Corp. (AGNC) reported third-quarter 2015 net spread and dollar roll income of 51 cents per share, missing the Zacks Consensus Estimate of 60 cents.
RSO: 11.59 (+0.04), ACAS: 14.51 (-0.20), AGNC: 17.95 (+0.04), ACRE: 12.41 (-0.12)

DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Resource Capital Corp. Of Upcoming Deadline
Business Wire - Sun Oct 25, 6:07AM CDT
Rigrodsky & Long, P.A.:
RSO: 11.59 (+0.04)

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Resource Capital Corp. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of November 9, 2015
Business Wire - Mon Oct 19, 11:01AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
RSO: 11.59 (+0.04)

UPCOMING DEADLINE ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Resource Capital Corp. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
Business Wire - Fri Oct 16, 9:35PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Resource Capital Corp. (NYSE: RSO) ("Resource Capital" or the "Company" securities during the period between March 2, 2015 and April 4, 2015, inclusive (the "Class Period". Investors who wish to become proactively involved in the litigation have until November 9, 2015 to seek appointment as lead plaintiff.
RSO: 11.59 (+0.04)

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Resource Capital Corp. to Recover Investor Losses - RSO
GlobeNewswire - Fri Oct 16, 6:26PM CDT
Rosen Law Firm, a global investor rights firm, announces that a class action lawsuit has been filed on behalf of all purchasers of Resource Capital Corp. (NYSE:RSO) securities from March 2, 2015 through August 4, 2015. The lawsuit seeks to recover investors' losses under the federal securities laws.
RSO: 11.59 (+0.04)

FINAL DEADLINE: Khang & Khang LLP Reminds Investors With Losses in Resource Capital Corp. of the Lead Plaintiff Deadline And Encourages Investors To Contact The Firm
Business Wire - Fri Oct 16, 2:30PM CDT
Khang & Khang LLP (the "Firm" reminds investors in Resource Capital Corp. ("Resource Capital" or the "Company" (RSO), who purchased or otherwise acquired shares between March 2, 2015 and August 4, 2015, inclusive (the "Class Period", of the November 9, 2015 deadline for lead plaintiff.
RSO: 11.59 (+0.04)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 81

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 194

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 229

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 147

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading

Top 5 Most Recently Viewed Articles

Container Store Group Faces Delisting by NYSE Amid Market Challenges

Updated Category News Views 145

Container Store Group's NYSE Delisting Announcement The New York Stock Exchange (NYSE) has made a significant announcement regarding the trading status of The Container Store Group, Inc. (TCS). The Exchange's staff has determined that it will initiate proceedings to delist the Company's common stock. This decision comes in light of the Company's recent performance in the...

Continue Reading
Investing in Vanguard Russell 2000 ETF: A Strategic Approach

Updated Category News Views 200

Investing in the Vanguard Russell 2000 ETF: A Strategic Approach In recent years, the stock market's performance has been largely driven by large corporations. While megacap tech stocks have thrived, small-cap stocks have struggled to keep pace. This has resulted in significant valuation discounts for smaller companies compared to their larger peers. Over the past five...

Continue Reading
Welcoming Ann Dunkin to Our Esteemed Board of Directors

Updated Category News Views 156

Ann Dunkin Joins Our Board of Directors We are thrilled to announce the appointment of Ann Dunkin, P.E., to our Board of Directors. With an extensive background in engineering and a strong commitment to public service, Ann's diverse expertise will be invaluable as we navigate the challenges and opportunities in our industry. Professional Background of Ann Dunkin Ann...

Continue Reading
Management Trading Insights on Unexpected Developments

Updated Category News Views 150

Understanding Management Trading Activities When assessing a company's health and future prospects, observing management trading can provide invaluable insights. Executive transactions—buying or selling shares—often reflect their confidence in the business's performance. An increase in stock purchases by management usually signals optimism, while significant sales may...

Continue Reading
Tovecimig's Efficacy in Biliary Tract Cancer Study Unveiled

Updated Category News Views 254

Breakthrough Findings in Biliary Tract Cancer Treatment Compass Therapeutics, Inc. has announced promising interim results from their ongoing Phase 2/3 study, COMPANION-002, examining the efficacy of tovecimig, formerly known as CTX-009, in combination with paclitaxel for treating advanced biliary tract cancer (BTC). Tovecimig, a bispecific antibody targeting both DLL4...

Continue Reading